Literature DB >> 17292823

The morphogenetic code and colon cancer development.

Gijs R van den Brink1, G Johan Offerhaus.   

Abstract

The initiating genetic lesion in sporadically occurring cancers is impossible to identify. The existence of rare inherited cancer syndromes has helped to uncover some of the mutations that can initiate tumorigenesis. Most of these initiating lesions affect genes belonging to morphogenetic signaling pathways. We review the evidence that the cellular fate of individual epithelial cells in the adult is nonautonomous and depends on extrinsic information, just like cells in a developing embryo. Cancer stem cells need to disrupt these extrinsic restraints to gain an autonomous clonal proliferative advantage over neighboring stem cells.

Entities:  

Mesh:

Year:  2007        PMID: 17292823     DOI: 10.1016/j.ccr.2007.01.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  32 in total

1.  Modelling spatially regulated beta-catenin dynamics and invasion in intestinal crypts.

Authors:  Philip J Murray; Jun-Won Kang; Gary R Mirams; Sung-Young Shin; Helen M Byrne; Philip K Maini; Kwang-Hyun Cho
Journal:  Biophys J       Date:  2010-08-04       Impact factor: 4.033

2.  When flies and mice develop cancer. Meeting on development and cancer.

Authors:  Offer Gerlitz; Erwin F Wagner; Eduardo Moreno
Journal:  EMBO Rep       Date:  2008-07-18       Impact factor: 8.807

3.  AP4 encodes a c-MYC-inducible repressor of p21.

Authors:  Peter Jung; Antje Menssen; Doris Mayr; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

4.  Role of stromal-epithelial interaction in the formation and development of cancer cells.

Authors:  Viktor Shtilbans
Journal:  Cancer Microenviron       Date:  2013-02-22

Review 5.  Models of carcinogenesis: an overview.

Authors:  Paolo Vineis; Arthur Schatzkin; John D Potter
Journal:  Carcinogenesis       Date:  2010-04-29       Impact factor: 4.944

6.  Personalised cancer care: promises and challenges of targeted therapy.

Authors:  Shi-Ming Tu; Mehmet A Bilen; Nizar M Tannir
Journal:  J R Soc Med       Date:  2016-03-01       Impact factor: 5.344

7.  A cancer theory kerfuffle can lead to new lines of research.

Authors:  Stuart G Baker
Journal:  J Natl Cancer Inst       Date:  2014-12-20       Impact factor: 13.506

8.  Nuclear receptor co-repressor is required to maintain proliferation of normal intestinal epithelial cells in culture and down-modulates the expression of pigment epithelium-derived factor.

Authors:  Geneviève Doyon; Stéphanie St-Jean; Mathieu Darsigny; Claude Asselin; Francois Boudreau
Journal:  J Biol Chem       Date:  2009-07-16       Impact factor: 5.157

9.  PDEF is a negative regulator of colon cancer cell growth and migration.

Authors:  Omar Moussa; David P Turner; Ron J Feldman; Victor I Sementchenko; Brent D McCarragher; Mohamed M Desouki; Mostafa Fraig; Dennis K Watson
Journal:  J Cell Biochem       Date:  2009-12-15       Impact factor: 4.429

Review 10.  Guanylyl cyclase C in colorectal cancer: susceptibility gene and potential therapeutic target.

Authors:  Jieru E Lin; Peng Li; Giovanni M Pitari; Stephanie Schulz; Scott A Waldman
Journal:  Future Oncol       Date:  2009-05       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.